期刊文献+

左旋门冬酰氨酶脱敏方法用于急性淋巴细胞白血病患儿的护理 被引量:3

Nursing care of desensitization treatment of L-asparaginasepaaginase
原文传递
导出
摘要 探讨左旋门冬酰氨酶脱敏疗法的应用及护理。应用脱敏方法对20例左旋门冬酰氨酶过敏的患儿进行脱敏治疗及护理, 19例患儿在脱敏治疗过程中无过敏反应发生,1例患儿出现轻微过敏反应,经处理后治疗顺利进行。20例患儿均顺利完成本疗程的左旋门冬酰氨酶化疗。强调脱敏过程中滴注速度应逐渐加快,做好患儿及家长的心理护理,细致周到的病情观察,准确无误的病情判断,及时有效的过敏抢救。经过脱敏疗法及护理后,再次发生过敏的几率小,且应用简便、易行,值得推广。 To explore the application of desensitization treatment of L-asparaginase (L-ASP) and nursing care. Apply the desensitization treatment of L-ASP and nursing care on 20 children with acute lymphobeytie leukemia (ALL). There was no allergic reaction in 19 children,slight allergic reaction occurred on only 1 child. After treatment,the desensitization treat ment still could carry on. All 20 children finished the desensitization treatment successfully. The emphasis of desensitization treatment was the speed of intravenous drip should increase gradually. The emphases of nursing care were :mental care to the children and their parents ,carefully observation ,correct judgement,in time and valid allergic treatment. The recurrent allergic reaction was very little. The application is simple and easy to perform. It is worthy of expansion.
出处 《中华护理杂志》 CSCD 北大核心 2009年第1期58-59,共2页 Chinese Journal of Nursing
关键词 左旋门冬酰胺酶 脱敏法 免疫 白血病 淋巴细胞 护理 L-asparaginase Desensitization,Immunologic Leukemia,Lymphocytic Nursing Care
  • 相关文献

参考文献4

二级参考文献14

  • 1Liboshi Y, Papst PS, Hunger SPL-asparaginase innibits the rapamycin-targeted signaling pathway. Biochem Biophys Res Communer, 1999,2600:534-539.
  • 2Alberts SR,Bretschdr M,Wiltsie JC,et al.Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia:a need to consider coagulation monitoring and clotting factor replacement.Leuk Lymphoma,1999,35(5-6):489-496.
  • 3Zubrod CG.The clinical toxicities of L-asparaginase in treatment of leukemia and lymphoma.Pediatrics,1970,45(4):555-559.
  • 4Hongo T,Okada S,Ohzeki T,et al.Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia:a retrospective study by the JACLS Japan Association of Childhood Leukemia Study.Pediatr Int,2002,44(3):293-370.
  • 5Elhasid R,Lanir N,Sharon R,et al.Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lymphoblastic leukemia.Blood Coagul Fibrinolysis,2001,12(5):236-370.
  • 6Andrew M,Brooker L,Mitchell L.Acquired antithrombin Ⅲ deficiency secondary to asparaginase therapy in children acute lymphoblastic leukemia.Blood Coagul Fibrinolysis,1994,5(Suppl 1):S24-S26.
  • 7Andreescu AC,Cushman M,Rosendaal FR.D-dimer as a risk factor for deep vein thrombosis:the Leiden Thrombophillia Study.Thromb Haemost 2002,87(1):47-51.
  • 8Cushman M,Folsom AR,Wang L,et al.Fibrin fragment D-dimer and the risk of future venous thrombosis.Blood,2003,101(4):1243-1248.
  • 9Foreman NK,Mabmound HH,Rivcta GK,et al.Recurrent cerebrovascular accident with L-asparaginase rechallenger.Med Pediatr Oncol,1992,20(6):532-534.
  • 10Imamura T,Morimoto A,kato Ret al.Cerebral thrombotic complication in adolescent leukemia/lymphoma patients treated with L-Asparaginase-containing chemotherapy.Leuk Lymphoma,2005,46(5):729-735.

共引文献8

同被引文献15

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部